ARIZONA CLINICAL TRIALS

The State’s Leading Source for Innovative Clinical Trials
Now Offering FDA-Approved COVID-19 Treatments for Qualified Individuals

Our passion is bringing new treatments and therapies for all patients through our vibrant clinical trials program. Volunteer for one of our studies today and help make a difference in healthcare.


COVID-19 Clinical Trials

Click to Learn More

COVID-19 Treatment

Click to Learn More



Board-Certified Providers


Our research team is headed by board-certified providers who specialize in infectious disease, internal medicine, and hepatology.  They have a combined 30+ years of experience in healthcare.



State-of-the-Art Clinical Trials Program


ACT providers hand-pick the best-suited clinical trials for their patients while using the latest state-of-the-art technology to research new therapies and treatments.



Excellent Patient Care


Our mission to provide the best patient care and treatment options through our clinical trials. In addition, we take extensive procedures and precautions to ensure the safety of our patients and staff.



LOCATIONS


MESA

2152 S Vineyard Ave
Bldg 8, Suite 123
Mesa, AZ 85210
480-360-4000


TUCSON

1601 N Swan Rd
Tucson, AZ 85712
520-445-4000


OUR TEAM

Arizona Clinical Trials is comprised of experienced clinical research coordinators who are passionate about finding innovative therapies for all patients. Our clinical trials include treatments for Fatty Liver Disease, NASH, cirrhosis and now COVID-19.

AZ Clinical Trials team


Current Enrolling Studies



Non-Alcoholic Fatty Liver Disease

NAFLD

NAFLD (Non-Alcoholic Fatty Liver Disease) or Fatty Liver, is a condition where the liver becomes infiltrated with fat. The fat is called steatosis; however, when flammation or scarring occurs, it is called steatohepatitis or NASH.


FIND OUT MORE


Non-Alcoholic Steatohepatitis

NASH

NASH means there is a presence of inflammation and scarring in the liver due to fatty infiltration or steatosis. This can progress to fibrosis, cirrhosis, liver failure and liver cancer. Up to 20% of the US population has fatty liver, and perhaps as many as 5% have NASH.


FIND OUT MORE


Advanced Liver Disease

CIRRHOSIS

Cirrhosis is a condition where the liver becomes heavily scarred (or fibrotic); this can occur as a result of alcohol, viral hepatitis, fatty liver disease, or any other type of chronic liver disease.


FIND OUT MORE

COVID-19 virus

Novel Coronavirus

COVID-19

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. There are many types of human coronaviruses, including some that commonly cause mild upper-respiratory tract illnesses.

COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans.


FIND OUT MORE

MESA

2152 S Vineyard Ave
Bldg 8, Suite 123
Mesa, AZ 85210


TUCSON

1601 N Swan Rd
Tucson , AZ 85712



Social networks


Facebook

www.facebook.com/azclinicaltrials


Twitter

@azclintrials


Instagram

@azclinicaltrials



Locations


Mesa Office

2152 S Vineyard Ave Ste 123
Mesa, AZ 85210
480-360-4000


Tucson Office

1601 N Swan Rd
Tucson, AZ 85712
520-445-4000


Call us to see if you or your patient qualify for a clinical trial.